Abstract:Background: Since its emergence in December 2019, COVID-19 has spread to over 210 countries, with an estimated mortality rate of 3-4%. Little is understood about its effects during pregnancy. Aims: To describe the current understanding of COVID-19 illness in pregnant women, to describe obstetric outcomes and to identify gaps in the existing knowledge. Methods: Medline Ovid, EMBASE, World Health Organization COVID-19 research database and Cochrane COVID-19 in pregnancy spreadsheet were accessed on 18/4, 18/5 and 23/5 2020. Articles were screened via Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The following were excluded: reviews, opinion pieces, guidelines, articles pertaining solely to other viruses, single case reports. Results: Sixty articles were included in this review. Some pregnant participants may have been included in multiple publications, as admission dates overlap for reports from the same hospital. However, a total of 1287 confirmed SARS-CoV-2 positive pregnant cases are reported. Where universal testing was undertaken, asymptomatic infection occurred in 43.5-92% of cases. In the cohort studies, severe and critical COVID-19 illness rates approximated those of the non-pregnant population. Eight maternal deaths, six neonatal deaths, seven stillbirths and five miscarriages were reported. Nineteen neonates were SARS-CoV-2 positive, confirmed by reverse transcription polymerase chain reaction of nasopharyngeal swabs. [Correction added on 2 September 2020, after first online publication: the number of neonates indicated in the preceding sentence has been corrected from 'Thirteen' to 'Nineteen'.] CONCLUSIONS: Where universal screening was conducted, SARS-CoV-2 infection in pregnancy was often asymptomatic. Severe and critical disease rates approximate those in the general population. Vertical transmission is possible; however, it is unclear whether SARS-CoV-2 positive neonates were infected in utero, intrapartum or postpartum. Future work should assess risks of congenital syndromes and adverse perinatal outcomes where infection occurs in early and mid-pregnancy.

A case series and literature review of blastomycosis during pregnancy amidst the COVID-19 crisis

An Unlikely Case of Blastomycosis in an Elderly Female: A Diagnostic Challenge in a Non-endemic Region

Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic — United States, 2019–2021

Safe Delivery for Pregnancies Affected by COVID‐19

Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients with Blastomycosis.

[Pregnant Women Complicated with COVID-19: a Clinical Analysis of 3 Cases].

Termination of Pregnancy Due to COVID-19 Induced Damage to the Placenta: A Case Report

COVID-19 in pregnancy and the puerperium: A review for emergency physicians

COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission

Case Report: Prenatal and Postnatal Management for Fetal Bronchogenic Cysts During the COVID-19 Pandemic

A Comprehensive Review of the Management of Pregnant Women with COVID-19: Useful Information for Obstetricians

COVID-19 positive woman presented with major fetal congenital anomalies: A case report with literature review

Obstetric Outpatient Management During the COVID-19 Pandemic: Prevention, Treatment of Mild Disease, and Vaccination

Exploring the Immunopathogenesis of Pregnancy with COVID-19 at the Vaccination Era

Severe course of COVID-19 in pregnant woman and newborn's alloimmune thrombocytopenia - case study and review of the literature

Impact of COVID-19 on Pregnancy and Childbirth: A Systematic Review of Recent Evidence

Pulmonary mucormycosis as a presentation of COVID 19: Case series

Review of Impact of COVID-19 on Maternal, Neonatal Outcomes, and Placental Changes

COVID-19 and Pregnancy

COVID-19 complicating pregnancy: A retrospective study of nine intensive care unit patients

Pulmonary blastoma in a pregnant woman: a case report and brief review of the literature